March 8, 2018 / 11:33 AM / 9 months ago

Germany's Merck seeks drug development partners

DARMSTADT, Germany, March 8 (Reuters) - German drugs and chemicals group Merck KGaA is open to sharing development costs for its mid-stage pharmaceuticals pipeline with external partners, it said on Thursday after flagging a decline in earnings this year.

“We are very open to partnerships ... we are in talks with many players,” Chief Executive Stefan Oschmann told a news conference after the release of fourth-quarter results, pointing in particular to evobrutinib, a so-called BTK inhibitor that suppresses autoimmune diseases such as rheumatoid arthritis. (Reporting by Ludwig Burger Editing by David Goodman)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below